Table 4 Characteristics of the study population and number of NS5A different sequences
From: New insights regarding HCV-NS5A structure/function and indication of genotypic differences
Patient # | Genotype | Therapy outcome | No. of sequences |
|---|---|---|---|
RF03 | 1A | ETR | 12 |
RF37 | 1A | ETR | 11 |
RF42 | 1B | ETR | 14 |
RF45 | 1A | ETR | 13 |
RF16 | 1A | NR | 13 |
RF22 | 1B | NR | 5 |
RF39 | 1B | NR | 3 |
RF44 | 1B | NR | 11 |
RF05 | 1B | R | 12 |
RF35 | 1A | R | 10 |
RF40 | 1A | R | 5 |
RF20 | 3 | ETR | 14 |
RF31 | 3 | ETR | 10 |
RF109 | 3 | ETR | 13 |
RF119 | 3 | ETR | 12 |
RF07 | 3 | NR | 12 |
RF60 | 3 | NR | 8 |
RF75 | 3 | NR | 12 |
RF145 | 3 | NR | 10 |
RF80 | 3 | R | 14 |
RF15 | 3 | R | 10 |
RF18 | 3 | R | 15 |
RF59 | 3 | R | 13 |
TOTAL | - | - | 252 |